NCT06796166 The Impact of AI- Supported Education in Mastectomy Patient
| NCT ID | NCT06796166 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bezmialem Vakif University |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2025-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-08-01 with a primary completion date of 2025-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the impact of artificial intelligence (AI)-supported preoperative education on fear and anxiety levels in patients undergoing total mastectomy. It is a randomized controlled trial involving two groups: one receiving AI-supported education and the other receiving standard preoperative education. The primary outcomes are to assess changes in surgical fear and anxiety levels. The study targets adult female patients diagnosed with breast cancer who are scheduled for total mastectomy.
Eligibility Criteria
Inclusion criteria: * Literate female patients * Patients who will undergo total mastectomy surgery * Patients diagnosed with breast cancer * Patients who are over 18 years of age * Patients who agree to participate in the study and from whom written consent has been obtained will be included in the study. Exclusion criteria: * Patients who cannot understand or communicate in Turkish * Patients with active psychiatric disorders (e.g., major depression, bipolar disorder, schizophrenia) * Patients with advanced hearing or vision problems * Patients with mental disabilities * Patients who have previously participated in a similar training program will be excluded from the study.
Contact & Investigator
Mahmut DAGCI, PhD
PRINCIPAL INVESTIGATOR
Bezmialem Foundation University
Frequently Asked Questions
Who can join the NCT06796166 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06796166 currently recruiting?
Yes, NCT06796166 is actively recruiting participants. Contact the research team at MDagci@bezmialem.edu.tr for enrollment information.
Where is the NCT06796166 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06796166 clinical trial?
NCT06796166 is sponsored by Bezmialem Vakif University. The principal investigator is Mahmut DAGCI, PhD at Bezmialem Foundation University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.